The Global Diabetic Assays Market is entering a "Golden Age" of diagnostic precision. Moving from a $3.5 Trillion valuation to over $5 Trillion by 2032, the market is buoyed by a CAGR of 7.95%. The data suggests that while the U.S. remains the financial anchor of the market, the growth in the hospital sector and the shift toward direct distribution channels will define the next decade... https://www.databridgemarketresearch.com/nucleus/global-diabetic-assays-market